We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular Death

Robert P. Blankfield, MD, MS
JAMA. 2012;307(12):1252-1253. doi:10.1001/jama.2012.352.
Text Size: A A A
Published online


To the Editor: The validity of the results of the meta-analysis by Dr Nguyen and colleagues1 regarding an association between androgen deprivation therapy (ADT) and cardiovascular death in patients with prostate cancer is suspect because the 8 studies that met the inclusion criteria may be biased. Androgen deprivation therapy was administered for a time interval that was less than the duration of data collection in 6 of the 8 studies, thereby introducing timing bias. In these 6 studies, ADT was administered for a period ranging from 3 months to 5.1 years, whereas the median duration of data collection in these studies ranged from 7.6 to 13 years. Because the time interval of ADT administration differs from the time interval of data collection in these studies, it is problematic to use them to test whether there is an association between ADT and cardiovascular death.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




March 28, 2007
Andrew T. Yan, MD; Raymond T. Yan, MD; Shaun G. Goodman, MD, MSc
JAMA. 2007;297(12):1313-1315. doi:10.1001/jama.297.12.1313-b.
March 28, 2012
Paul L. Nguyen, MD; Youjin Je, MS; Toni K. Choueiri, MD
JAMA. 2012;307(12):1252-1253. doi:10.1001/jama.2012.353.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.